DISC MEDICINE INC. shares soared 41% after the company announced the results of the phase III clinical trial of BITOPERTIN.

Zhitongcaijing · 3d ago
DISC MEDICINE INC. shares soared 41% after the company announced the results of the phase III clinical trial of BITOPERTIN.